You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

low-dose interleukin-2

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Sjögren's Syndrome Trial in Beijing (low-dose interleukin-2, rapamycin)

Recruiting
  • Sjögren's Syndrome
  • Beijing, Beijing, China
    Peking university people's hospital
Dec 2, 2022

TIA, Carotid Artery Plaque, Carotid Atherosclerosis Trial in Cambridge (Interleukin-2 [IL-2], Standard care - Carotid

Not yet recruiting
  • TIA
  • +2 more
  • Interleukin-2 [IL-2]
  • Standard care - Carotid Endarterectomy
  • Cambridge, Cambridgeshire, United Kingdom
    Addenbrookes Hospital
Aug 2, 2023

Pancreatic Cancer, Surgery, Metastasis Trial (Histamine DiHCl (HDC), Interleukin-2 (IL-2))

Not yet recruiting
  • Pancreatic Cancer
  • +3 more
  • Histamine Dihydrochloride (HDC)
  • Interleukin-2 (IL-2)
  • (no location specified)
Mar 31, 2023

Acute Coronary Syndromes Trial in Cambridge (Interleukin-2 [IL-2], Placebo Dextrose 5% solution)

Recruiting
  • Acute Coronary Syndromes
  • Interleukin-2 [IL-2]
  • Placebo Dextrose 5% solution
  • Cambridge, Cambridgeshire, United Kingdom
    Addenbrooke's Hospital
May 31, 2022

Pleural Mesothelioma Trial in Toronto (Cyclophosphamide, Fludarabine, Autologous tumor infiltrating lymphocytes (TILs))

Completed
  • Pleural Mesothelioma
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Jan 8, 2023

Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8, Stage IVA Lung Cancer AJCC v8 Trial in Atlanta (Aldesleukin,

Not yet recruiting
  • Lung Non-Small Cell Carcinoma
  • +3 more
  • Aldesleukin
  • Pembrolizumab
  • Atlanta, Georgia
    Emory University/Winship Cancer Institute
Aug 8, 2022

Alzheimer Trial in Houston (Aldesleukin)

Completed
  • Alzheimer Disease
  • Houston, Texas
    Alireza Faridar
Apr 19, 2023

Ischemic Heart Disease Trial in Cambridge (Proleukin, Placebo Injection)

Completed
  • Ischemic Heart Disease
  • Cambridge, Cambridgeshire, United Kingdom
    Addenbrooke's Hospital
Sep 10, 2021

Type 1 Diabetes Trial (Cyclosporin, ILT101, Placebo)

Not yet recruiting
  • Type 1 Diabetes
  • (no location specified)
Dec 9, 2021

Leiomyosarcoma Trial in Bad Saarow, Berlin (Dinutuximab Beta, Zoledronic acid, Interleukin-2)

Recruiting
  • Leiomyosarcoma
  • Dinutuximab Beta, Zoledronic acid, Interleukin-2
  • Bad Saarow, Germany
  • +1 more
Jun 2, 2022

Chronic GVHD Trial in Duarte (biological, procedure, other)

Active, not recruiting
  • Chronic Graft Versus Host Disease
  • Aldesleukin
  • +3 more
  • Duarte, California
    City of Hope Medical Center
Jan 4, 2023

Chronic Spontaneous Urticaria Trial in Changsha (Recombinant human interleukin-2 (rhIL-2), Control group)

Not yet recruiting
  • Chronic Spontaneous Urticaria
  • Recombinant human interleukin-2 (rhIL-2)
  • Control group
  • Changsha, Hunan, China
    The Second Xiangya Hospital of Central South University
May 15, 2021

Systemic Lupus Erythematosus, Lupus Nephritis Trial in Nanjing (Human umbilical cord mesenchymal stem cells, Interleukin-2)

Recruiting
  • Systemic Lupus Erythematosus
  • Lupus Nephritis
  • Nanjing, Jiangsu, China
    The Affiliated Nanjing Drum Tower Hospital of Nanjing University
Nov 20, 2022

Alzheimer Trial in Paris (Proleukin, Placebo)

Not yet recruiting
  • Alzheimer Disease
  • Paris, France
    GHU Saint Anne
Jul 18, 2022

Diabetes, Type 1, Hypoglycemia, Autoimmune Diseases Trial in Miami (Anti-Thymocyte Globulin (ATG), Interleukin 2, Exenatide)

Not yet recruiting
  • Diabetes Mellitus, Type 1
  • +3 more
  • Anti-Thymocyte Globulin (ATG)
  • +7 more
  • Miami, Florida
    Diabetes Research Institute, University of Miami Miller School o
Feb 23, 2022

GVHD Trial in Hackensack (Cyclophosphamide and Sirolimus, Low dose IL-2 with Cytoxan + Sirolimus, Low dose IL-2, low dose

Terminated
Has Results
  • Graft Versus Host Disease
  • Cyclophosphamide and Sirolimus
  • +3 more
  • Hackensack, New Jersey
    John Theurer Cancer Center at Hackensack University Medical Cent
Feb 4, 2022

Melanoma Stage III, Melanoma Stage IV, Inoperable Disease Trial in Tampa (Interleukin-2, Ipilimumab, Nivolumab)

Recruiting
  • Melanoma Stage III
  • +2 more
  • Tampa, Florida
    Moffitt Cancer Center
Dec 6, 2022

Amyotrophic Lateral Sclerosis Trial in France, United Kingdom (Riluzole, IL-2, 5% glucose water solution)

Completed
  • Amyotrophic Lateral Sclerosis
  • Lille, France
  • +16 more
Apr 1, 2022

Hematopoietic Stem Cell Transplantation Trial in Nantes (IL2, Zoledronic Acid)

Recruiting
  • Hematopoietic Stem Cell Transplantation
  • IL2
  • Zoledronic Acid
  • Nantes, France
    Nantes Uh
Mar 29, 2022

Systemic Lupus Erythematosus Trial in Beijing (Belimumab, Interleukin-2)

Recruiting
  • Systemic Lupus Erythematosus
  • Beijing, China
    Department of Rheumatology and Immunology, Peking University Peo
Mar 24, 2022

HIV Trial in United States (Aldesleukin)

Completed
  • HIV Infections
  • Birmingham, Alabama
  • +9 more
Oct 27, 2021

Systemic Lupus Erythematosus Trial in Beijing (Telitacicept, Interleukin-2)

Recruiting
  • Systemic Lupus Erythematosus
  • Beijing, Beijing, China
    Department of Rheumatology and Immunology, Peking University Peo
Apr 26, 2022

Ulcerative Colitis Trial in Boston (Interleukin-2 (aldesleukin).)

Completed
Has Results
  • Ulcerative Colitis
  • Interleukin-2 (aldesleukin).
  • Boston, Massachusetts
  • +1 more
Aug 3, 2021

Metastatic Melanoma, Stage IIIB Cutaneous Melanoma AJCC v7, Stage IIIC Cutaneous Melanoma AJCC v7 Trial in Houston (biological,

Completed
  • Metastatic Melanoma
  • +3 more
  • Aldesleukin
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 27, 2022

Liver Transplantation Trial in Boston (Interleukin-2)

Active, not recruiting
  • Liver Transplantation
  • Interleukin-2
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
May 25, 2021